Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Intercept Pharma Raises US$30 Million In Series C Financing 10
Partnerships 12
Intercept Pharma Extends Agreement with Target Pharma 12
Intercept Pharma Enters into Research Agreement with University of Perugia 13
Equity Offering 14
Intercept Pharma Prices Private Placement of Shares for USD100 Million 14
Intercept Pharma Prices Public Offering of Shares for USD150 Million 16
Intercept Pharma Raises USD367.3 Million in Public Offering of Shares 18
Intercept Pharma Raises USD202 Million in Public Offering of Shares 20
Intercept Pharma Completes Public Offering Of Shares For US$192 Million 22
Intercept Pharma Completes Public Offering Of Shares For US$65.7 Million 24
Intercept Pharma Completes Underwriters’ Exercise Of Over-Allotment Option For US$86 Million 26
Debt Offering 28
Intercept Pharma Raises USD460 Million in Public Offering of 3.25% Notes Due 2023 28
Intercept Pharmaceuticals Inc – Key Competitors 30
Intercept Pharmaceuticals Inc – Key Employees 31
Intercept Pharmaceuticals Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 34
Financial Announcements 34
Oct 31, 2018: Intercept Pharmaceuticals reports third quarter 2018 financial results and provides business update 34
Aug 02, 2018: Intercept Pharmaceuticals reports second quarter 2018 financial results and provides business update 36
May 08, 2018: Intercept Pharmaceuticals Announces First Quarter 2018 Financial Results, Issues 2018 Ocaliva Net Sales Guidance and Provides Business Update 38
Feb 14, 2018: Intercept Pharmaceuticals Reports Net Sales Of $129.2 Million For The Year Ended December 31, 2017 40
Jul 31, 2017: Intercept Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update 43
May 04, 2017: Intercept Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update 45
Feb 23, 2017: Intercept Pharmaceuticals Reports Full Year 2016 Financial Results and Provides Business Update 47
Corporate Communications 50
Nov 27, 2017: Intercept Pharmaceuticals Appoints Christian Weyer as Executive Vice President of Research & Development 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Intercept Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Intercept Pharma Raises US$30 Million In Series C Financing 10
Intercept Pharma Extends Agreement with Target Pharma 12
Intercept Pharma Enters into Research Agreement with University of Perugia 13
Intercept Pharma Prices Private Placement of Shares for USD100 Million 14
Intercept Pharma Prices Public Offering of Shares for USD150 Million 16
Intercept Pharma Raises USD367.3 Million in Public Offering of Shares 18
Intercept Pharma Raises USD202 Million in Public Offering of Shares 20
Intercept Pharma Completes Public Offering Of Shares For US$192 Million 22
Intercept Pharma Completes Public Offering Of Shares For US$65.7 Million 24
Intercept Pharma Completes Underwriters' Exercise Of Over-Allotment Option For US$86 Million 26
Intercept Pharma Raises USD460 Million in Public Offering of 3.25% Notes Due 2023 28
Intercept Pharmaceuticals Inc, Key Competitors 30
Intercept Pharmaceuticals Inc, Key Employees 31
Intercept Pharmaceuticals Inc, Other Locations 32
Intercept Pharmaceuticals Inc, Subsidiaries 32
List of Figures
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Intercept Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8